NYSE:BAX - Baxter International Stock Price, News, & Analysis

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International declared a quarterly dividend on Tuesday, November 13th. Investors of record on Monday, December 3rd will be given a dividend of $0.19 per share on Wednesday, January 2nd. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date of this dividend is Friday, November 30th. View Baxter International's Dividend History.

Baxter International declared that its Board of Directors has authorized a share buyback program on Tuesday, November 13th 2018, which permits the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 6.1% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's management believes its stock is undervalued.

Baxter International Inc (NYSE:BAX) released its quarterly earnings results on Wednesday, October, 31st. The medical instruments supplier reported $0.80 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.74 by $0.06. The medical instruments supplier earned $2.77 billion during the quarter, compared to analyst estimates of $2.79 billion. Baxter International had a return on equity of 17.67% and a net margin of 10.90%. The business's revenue was up 2.2% compared to the same quarter last year. During the same period last year, the business posted $0.64 earnings per share. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, January 31st 2019. View Earnings Estimates for Baxter International.

Baxter International issued an update on its fourth quarter earnings guidance on Wednesday, October, 31st. The company provided earnings per share (EPS) guidance of $0.71-0.73 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.77. Baxter International also updated its FY 2018 guidance to $2.98-3.00 EPS.

16 brokers have issued 12 month price objectives for Baxter International's stock. Their predictions range from $70.00 to $85.00. On average, they anticipate Baxter International's share price to reach $76.1250 in the next year. This suggests a possible upside of 10.1% from the stock's current price. View Analyst Price Targets for Baxter International.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 1 sell rating, 2 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

News articles about BAX stock have been trending very positive recently, InfoTrie reports. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Baxter International earned a news impact score of 3.7 on InfoTrie's scale. They also assigned media stories about the medical instruments supplier a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future.

Some companies that are related to Baxter International include 3M (MMM), Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ResMed (RMD), ABIOMED (ABMD), DexCom (DXCM), Teleflex (TFX), Hill-Rom (HRC), Haemonetics (HAE), ICU Medical (ICUI), Penumbra (PEN), Insulet (PODD) and Globus Medical (GMED).

Baxter International's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Gateway Investment Advisers LLC (0.08%), Retirement Systems of Alabama (0.06%), Nisa Investment Advisors LLC (0.04%), Sit Investment Associates Inc. (0.03%), Palisade Asset Management LLC (0.03%) and Gulf International Bank UK Ltd (0.02%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Sit Investment Associates Inc., Boston Advisors LLC, Gulf International Bank UK Ltd, First Citizens Bank & Trust Co., Carroll Financial Associates Inc., Oakbrook Investments LLC, First Midwest Bank Trust Division and DNB Asset Management AS. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, John D Forsyth, Peter S Hellman, Scott Pleau and Third Point Llc. View Insider Buying and Selling for Baxter International.

BAX stock was bought by a variety of institutional investors in the last quarter, including Meeder Asset Management Inc., New England Research & Management Inc., Town & Country Bank & Trust CO dba First Bankers Trust CO, Steward Partners Investment Advisory LLC, State of Alaska Department of Revenue, Palisade Asset Management LLC, BKD Wealth Advisors LLC and Retirement Systems of Alabama. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $69.12.

Baxter International has a market capitalization of $35.94 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

The official website for Baxter International is http://www.baxter.com.

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]